Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

468 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatic artery ligation with and without portal infusion of 5-FU. A randomized study in patients with unresectable liver metastases from colorectal carcinoma. The E.O.R.T.C. Gastrointestinal Cancer Cooperative Group (G.I. Group).
Gerard A, Buyse M, Pector JC, Bleiberg H, Arnaud JP, Willems G, Delvaux G, Lise M, Nitti D, Depadt G, et al. Gerard A, et al. Among authors: buyse m. Eur J Surg Oncol. 1991 Jun;17(3):289-94. Eur J Surg Oncol. 1991. PMID: 2044783 Clinical Trial.
Randomized phase II study of a combination of cisplatin (DDP), 5-fluorouracil (5-FU), and allopurinol (HPP) versus 5-FU in advanced colorectal carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group study.
Bleiberg H, Vanderlinden B, Buyse M, Haegele P, Paillot B, Tagnon A, Wils J, Cartei G, Fornasiero A, Duez N. Bleiberg H, et al. Among authors: buyse m. Cancer Invest. 1990;8(5):471-5. doi: 10.3109/07357909009012070. Cancer Invest. 1990. PMID: 2265371 Clinical Trial.
An EORTC gastrointestinal (GI) group randomized evaluation of the toxicity of sequential high dose methotrexate and 5-fluorouracil combined with adriamycin (FAMTX) vs 5-fluorouracil, adriamycin and mitomycin (FAM) in advanced gastric cancer.
Klein HO, Wils J, Bleiberg H, Buyse M, Duez N. Klein HO, et al. Among authors: buyse m. Med Oncol Tumor Pharmacother. 1989;6(2):171-4. doi: 10.1007/BF02985241. Med Oncol Tumor Pharmacother. 1989. PMID: 2664372 Clinical Trial.
Adjuvant FAM2 in resectable gastric cancer.
Lise M, Nitti D, Buyse M, Marchet A, Fiorentino M, Dos Santos JG, Duez N. Lise M, et al. Among authors: buyse m. Anticancer Res. 1989 Jul-Aug;9(4):1017-21. Anticancer Res. 1989. PMID: 2683987 Clinical Trial.
Interim analysis of a double-blind phase-III clinical trial of adjuvant levamisole versus control in resectable Dukes-C colon cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group.
Arnaud JP, Buyse M, Adloff M, Nordlinger B, Pector JC, Duez N. Arnaud JP, et al. Among authors: buyse m. Recent Results Cancer Res. 1988;110:101-3. doi: 10.1007/978-3-642-83293-2_14. Recent Results Cancer Res. 1988. PMID: 3043583 Clinical Trial. No abstract available.
468 results